Cargando…
Pharmacovigilance in High-Income Countries: Current Developments and a Review of Literature
The world bank has classified 80 economies based on their Gross National Income (GNI) per capita as High-Income. European Medicines Agency (EMA), Food and Drug Administration (FDA), and Pharmaceuticals and Medical Devices Agency (PMDA) are the major regulatory stakeholders driving global pharmacovig...
Autores principales: | Khan, Muhammad Akhtar Abbas, Hamid, Saima, Babar, Zaheer-Ud-Din |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844306/ https://www.ncbi.nlm.nih.gov/pubmed/36649020 http://dx.doi.org/10.3390/pharmacy11010010 |
Ejemplares similares
-
Assessment of the Current State of Pharmacovigilance System in Pakistan Using Indicator-Based Assessment Tool
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022) -
A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022) -
Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
por: Babar, Zaheer-Ud-Din
Publicado: (2021) -
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022) -
Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)